The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hi Gixxer,
I agree but I struggle to see how they will have something like that which can be in an RNS before some time after the final assays have been received. I am more than happy to be wrong about that. I also think whatever we get needs to be via RNS in order to catch the attention of more investors.
Personally I'm hoping/expecting a lot more than we got last time - CB's been shouting for a while now that we have a T1 asset, we will hit the 2MT target, it's a big etc.....
The next release of an updated open pit model, and subsequent presentation, needs to be something special IMO. It needs to be such that AA can decide if they want in or out. Hopefully out so we can have a bit of a bidding war with those that want in.
I assume we will get an update when MMP have completed production and start comissioning the plant?
In terms of a model I wonder if we could get something similar to the original long section we got for Racecourse. If we could get a few of these diagrams showing the drill results and extrapolated mineralisation, with grades and some mechanism to aid understanding of where the new areas of mineralisation are it would help. I realise that we already have a lot of cross section diagrams but I find it difficult to extrapolate these into an expanded resource. I think we need something in an RNS to convince investors. Unsurprisingly I also want to see what the model of the higher grade gold area shows...
Thank you for your forecasted income figures andrew4444
Just for an added reference on costs
>>> Note. These figures are profit, so after all costs and tax. Not headline revenue figures.
So roughly 60k monthly for costs going by the half year report.
Any figures been quoted on full production when it ramps up later next year ?
Or potentially what that figure could be?
Can you send another one asking for an updated model please. I have no chimney. Thanks
Me too lucky...... seems like Santa Claus might be answering letters from big boys too. I sent it up the chimney last week.
Thats great Andy, so a bit of an improvement on what was stated in their last video....where they thought Q1 for production.... Andrea is now saying that they have had a great amount of discussion with MMP on their construction progress and they are expecting to get into production by year end (only 5 weeks guys)...... with revenues in Q1.
So it looks like they have managed to pull this in a little.
Shame we need to hear it via Empress but I suppose in terms of the priorities for MMP....... money talks, we just hold the licence.
So possible production at manica in December or January. That's sounds more positive.
I imagine if she says end of this year or Q1 next year it's not going to be February or March.
Will be very pleased when xtract release the statement, manica is in production!
Face
I posted this below on 14 Oct. I think I will stick with those income figures but may need to move Eureka time scale to Q2? (Unless we get a positive update soon).
Alluvial income was much higher than £50K a month for last quarter but that was a very good quarter and its very random and unpredictable.
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
Hostage to fortune giving anticipated monthly income figures, but my best guess by end of Q1 is:
Fairbride £350K
Alluvial £50K
GF + BE £150K
Eureka £200K
Total £750K a month profit by end of Q1 .
Note. These figures are profit, so after all costs and tax. Not headline revenue figures
Thanks. I know the main focus for XTR is on Bushranger, but I know this will be important too. Does anyone have a sense of quantum of revenue the projects within XTR that are or will soon be producing revenue?
https://www.youtube.com/watch?v=Oz6SpaX5e54
Quick manica reference at 1m 55 sec.
Interview 22 Nov